Relation

Using machine learning to understand the biology underlying disease

First Investment: 2021

Finding new drugs to treat disease requires understanding the exact changes in gene and protein expression that make patients sick. Relation Therapeutics is using active graph machine learning, a mathematical method adapted from consumer social networking, to study data from individual human cells to find the most promising ways to treat disease, starting with osteoporosis.

News & Insights

Deep Tech Opportunities Report

DCVC DTOR 2024: In the AI race, data will emerge as the critical asset

DCVC leads $35 million financing to help UK TechBio leader Relation Therapeutics to seek new treatments for complex diseases

By Jason Pontin, Zachary Bogue

In The Media

‘ChatGPT for DNA’: Relation nabs $35M, with Nvidia backing, for osteoporosis work

Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report

Explore Companies

Syntax Bio

Programming stem cells to differentiate into desired cell types, faster

Fable Therapeutics

Using state-of-the-art machine learning models to create custom-build protein drugs

Nilo Therapeutics

Mapping the brain-body axis to achieve proper immune balance

Avicenna Biosciences

Using AI to speed through the last mile of drug discovery